World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 33510545

Number of visits today: 4332

Number of downloads: 16697273

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Shi P, Liu Y, Yang D, Wu Y, Zhang L, Jing S, Shi H, Geng C. CircRNA ZNF609 promotes the growth and metastasis of thyroid cancer in vivo and in vitro by downregulating miR-514a-5p. Bioengineered 2022;13:4372-84. [PMID: 35135416 DOI: 10.1080/21655979.2022.2033015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]

For:

Shi P, Liu Y, Yang D, Wu Y, Zhang L, Jing S, Shi H, Geng C. CircRNA ZNF609 promotes the growth and metastasis of thyroid cancer in vivo and in vitro by downregulating miR-514a-5p. Bioengineered 2022;13:4372-84. [PMID: 35135416 DOI: 10.1080/21655979.2022.2033015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]

Number	Citing Articles
1	Yang C, Cao ZG, Zhou ZW, Han SJ. Circ0005654 as a new biomarker of thyroid cancer interacting with SP1 to influence the prognosis: A case-control study. Medicine (Baltimore) 2023;102:e32853. [PMID: 36820560 DOI: 10.1097/MD.0000000000032853] [Reference Citation Analysis]
2	Luo J, Wang S, Zhang L, Zhang L, Wu S, Zheng W, Huang X, Ye X, Wu M. Research advance and clinical implication of circZNF609 in human diseases. Biotechnology & Biotechnological Equipment 2022;36:668-683. [DOI: 10.1080/13102818.2022.2118076] [Reference Citation Analysis]
3	Ghazimoradi MH, Babashah S. The role of CircRNA/miRNA/mRNA axis in breast cancer drug resistance. Front Oncol 2022;12:966083. [DOI: 10.3389/fonc.2022.966083] [Reference Citation Analysis]
4	Yao X, Zhang Q. Function and Clinical Significance of Circular RNAs in Thyroid Cancer. Front Mol Biosci 2022;9:925389. [DOI: 10.3389/fmolb.2022.925389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5	Xin Y, Shang X, Sun X, Xu G, Liu Y, Liu Y. SLC8A1 antisense RNA 1 suppresses papillary thyroid cancer malignant progression via the FUS RNA binding protein (FUS)/NUMB like endocytic adaptor protein (Numbl) axis. Bioengineered 2022;13:12572-82. [DOI: 10.1080/21655979.2022.2073125] [Reference Citation Analysis]
6	Jiang Q, Wang H, Yuan D, Qian X, Ma X, Yan M, Xing W. Circular_0086414 induces SPARC like 1 (SPARCL1) production to inhibit esophageal cancer cell proliferation, invasion and glycolysis and induce cell apoptosis by sponging miR-1290. Bioengineered 2022;13:12099-114. [PMID: 35549806 DOI: 10.1080/21655979.2022.2073114] [Reference Citation Analysis]
7	Yan J, Zhu J, Zhu X, Liu H, Chen G. Circ_0092012 knockdown restrains non-small cell lung cancer progression by inhibiting cell malignant phenotype and immune escape through microRNA-635/programmed death ligand 1 axis. Bioengineered 2022;13:13929-43. [PMID: 35723188 DOI: 10.1080/21655979.2022.2080386] [Reference Citation Analysis]